SAPHNELO 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

Astrazeneca Ab🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: f43f970e1acc2175
Drug Cima Aemps Name: SAPHNELO 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1211623001
Holder Company Name: Astrazeneca Ab
Marketing Company Name: Astrazeneca Farmaceutica Spain S.A.
Holder Company Detail Path: /organization/astrazeneca-ab
Authorization Date: 2022-03-18
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 300 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Astrazeneca Ab
Company Detail Path: /organization/astrazeneca-ab

ANIFROLUMAB

300 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 18, 2022

Approval ID

f43f970e1acc2175

Type

Standard